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For the Netherlands, in 2011 a total of 830,000 individu-
als (415,900 male, 418,200 female) were known with diabe-
tes mellitus, of whom 90 % with type 2 diabetes. Prevalence 
was highest in the age group between 75 and 85 years and 
already 600,000 individuals between 30 and 70 years were 
known to have diabetes [3].
Patients with diabetes have a high risk of adverse cardiac 
events [4, 5]. A total of 281 million men and 317 million 
women worldwide with diabetes died in 2011, most from 
cardiovascular disease in particular coronary artery disease 
(CAD). CAD is often silent in diabetes patients and up to 
60 % of myocardial infarctions may be asymptomatic, diag-
nosed only by ECG stress testing, myocardial scintigraphy 
or stress echocardiography. Silent myocardial ischaemia 
affects 20–35 % of diabetes patients who have additional 
risk factors, and 35–70 % of patients with silent ischaemia 
have significant coronary stenosis at coronary arteriography.
In asymptomatic patients, routine screening for CAD is 
controversial [6–8]. It is not recommended by the Ameri-
can Diabetes Association (ADA), since it does not improve 
outcomes as long as cardiovascular risk factors are treated. 
This position is, however, under serious debate and the char-
acteristics of the patients who should be screened for CAD 
need to be better defined. To that purpose, several imaging 
strategies have proposed to screen for CAD in asymptom-
atic diabetic patients [9–14].
To further expand the value of imaging strategies in 
asymptomatic diabetes, the FACTOR-64 trial was per-
formed and presented at the November 2014 meeting of 
the American Heart Association (AHA) and simultaneously 
published in the Journal of the American Medical Associa-
tion (JAMA) [15]. The FACTOR-64 trial is entitled: Screen-
ing for Asymptomatic Obstructive Coronary Artery Disease 
Among High-Risk Diabetic Patients Using CT Angiography. 
This randomised, blinded parallel trial evaluated the effi-
According to the 2013 ESC Guidelines on diabetes, pre-dia-
betes, and cardiovascular diseases, developed in collabora-
tion with the European Association for the Study of Diabetes 
(EASD), approximately 360 million people worldwide had 
diabetes in 2011, of whom > 90 % with type 2 diabetes [1]. 
This number will increase to 552 million by the year 2030. 
Another 300 million individuals showed features indicating 
future risk of developing type 2 diabetes, including fasting 
hyperglycaemia, impaired glucose tolerance, gestational 
diabetes and euglycaemic insulin resistance. The majority 
of new cases of type 2 diabetes occur in the context of West-
ernised lifestyles, high-fat diets and decreased exercise, 
leading to increasing levels of obesity, insulin resistance 
and, ultimately, beta-cell failure and type 2 diabetes [2]. The 
Middle East, the Asia–Pacific rim and parts of both North 
and South America have experienced massive increases in 
the prevalence of diabetes over the past 20 years, changes 
mirrored in European populations over the same period. 
For Europe, the International Diabetes Federation’s global 
estimates for 2011 suggested that 52 million Europeans 
aged 20–79 years have diabetes and that this number will 
increase to over 64 million by the year 2030. The healthcare 
expenditure for diabetes in Europe was about 75 billion € in 
2011 and is projected to increase to 90 billion € by the year 
2030. Awareness of specific issues associated with gender 
and race and, particularly, the effects of diabetes in women 
are becoming of increasing importance.
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cacy of routine screening for CAD in patients with type 1 or 
2 diabetes and no overt symptoms of CAD. The hypothesis 
was that CAD screening with coronary computed tomogra-
phy angiography (CCTA) in patients with diabetes mellitus 
and no known CAD would reduce cardiovascular outcomes 
compared with routine management, i.e. standard national 
guidelines–based optimal diabetes care. It was assumed that 
routine CCTA-guided CAD screening and directed therapy 
would be superior to routine management in cardiovascu-
lar risk reduction in patients with diabetes of at least 3–5 
years’ duration. Coronary arteriography and coronary artery 
calcium (CAC) levels were performed on a Toshiba Aquil-
lon 64 CT scanner. Scan results were classified as severe 
stenosis (≥ 70 % stenosis in at least one major proximal or 
large coronary artery; recommendation to pursue coronary 
angiography), moderate stenosis (50–69 % stenosis or CAC 
> 100; recommendation to pursue stress testing), mild ste-
nosis (10–49 % stenosis or CAC > 10–100; no further imag-
ing recommended) or normal (< 10 % stenosis and CAC 
≤ 10; no further imaging recommended).
In the FACTOR 64-trial, a total of 900 patients were ran-
domised: 452 to CCTA and 448 patients to routine manage-
ment. The patient population consisted of men ≥ 50 years 
old with at least a 3-year history of diabetes or ≥ 40 years 
old with at least a 5-year history of diabetes (52 %), and 
women ≥ 55 years old with at least a 3-year history of diabe-
tes or ≥ 45 years old with at least a 5-year history of diabe-
tes, all patients on antidiabetic medication for at least 1 year. 
Baseline characteristics were fairly similar between the two 
arms. Mean duration of diabetes was 13 years, and 20 % 
of the patients were on insulin only, with another 23 % on 
both insulin and noninsulin agents. The primary endpoint 
was a composite of all-cause mortality, nonfatal myocardial 
infarction, and hospitalisation for unstable angina.
In the CCTA arm, the median CAC score was 55, with 
41 % having Agatston scores ≥ 100. About 21 % had mod-
erate or severe stenosis on CCTA. An aggressive medical 
regimen was adopted in 70 % of subjects in the CCTA arm. 
The primary endpoint was similar between the CCTA and 
routine management arms (6.2 vs. 7.6 %). All-cause mortal-
ity (3.5 vs. 4.3 %), nonfatal myocardial infarction (1.5 vs. 
1.8 %), cardiovascular death (1.5 vs. 1.8 %), CAD death 
(1.1 vs. 0.4 %) and stroke/carotid revascularisation proce-
dure (1.8 vs. 2.0 %) were all similar between the two arms; 
hospitalisation for congestive heart failure was lower in the 
CCTA arm (0.7 vs. 2.2 %, p = 0.04).
To summarise, the results of the FACTOR-64 trial 
indicate that routine screening for CAD in asymptomatic 
patients with diabetes using CCTA was not beneficial in 
reducing cardiovascular events compared with routine man-
agement. To put it short: these data do not support routine 
CCTA screening in this population. The findings rather sug-
gest that focused prevention with optimal guideline-directed 
medical therapy in asymptomatic patients with diabetes is 
far more important than using a routine cardiac imaging 
strategy. This reinforces the importance of aggressive risk 
factor and lifestyle modification in patients with diabetes 
mellitus.
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